SCHEMBL22247070

SCHEMBL22247070

CCC1CCC[C@@H](O[C@@H]2OC(CO)[C@H](O)C(O[C@@H](CC3CCCCC3)C(=O)O)C2NC(=O)CN)C1O[C@@H]1OC(C)[C@@H](O)C(O)C1O

nearest known ligand 0.71

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SELE P16581 19/20 0.71
▸ CD209 Q9NNX6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22247343 0.92 SELE (0.70) SELE
SCHEMBL16659817 0.92 SELE (0.74) SELE
SCHEMBL22247334 0.91 SELE (0.65) SELE
SCHEMBL15070099 0.90 SELE (0.70) SELE
SCHEMBL17881698 0.90 SELE (0.70) SELE
SCHEMBL16659815 0.90 SELE (0.70) SELE
SCHEMBL18027906 0.88 SELE (0.71) SELE
SCHEMBL16661828 0.88 SELE (0.71) SELE
SCHEMBL22247085 0.87 SELE (0.71) SELE
SCHEMBL18026351 0.86 SELE (0.64) SELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020150263-A1 SELECTIN OR GALECTIN ANTAGONISTS FOR TREATING CYTOKINE RELEASE SYNDROME AND CRS-INDUCED NEUROTOXICITY MAGNANI JOHN L (US) 2020-07-23 — — WO disclosed
Send feedback